Concepedia
Statistics
Publications
8
Citations
652
H-Index
Active since
1993
Affiliations
Allergan (Ireland)(Current)
University of Arizona
Institute of Pharmacology
Craig Fairbairn is an author at Allergan (Ireland) specializing in pharmacology, medicine, and molecular pharmacology.
Publications per year
1993–2017
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
John W. Regan, Thomas J. Bailey, D.J. Pepperl et al. · Molecular Pharmacology · 1994 · 396 citations
Medicine, Pharmacology, Cell Signaling +14
Molecular cloning and expression of human EP<sub>3</sub> receptors: evidence of three variants with differing carboxyl termini
John W. Regan, Thomas J. Bailey, John E. Donello et al. · British Journal of Pharmacology · 1994 · 99 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
David F. Woodward, Ruth A. Lawrence, Craig Fairbairn et al. · PubMed · 1993 · 35 citations
Medicine, Ophthalmology, Pharmacology +12
Stability of AMH measurement in blood and avoidance of proteolytic changes
Richard Fleming, Craig Fairbairn, Catherine Blaney et al. · Reproductive BioMedicine Online · 2012 · 29 citations · Full text
Life Sciences, Biochemistry, Physiology +10
Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP <sub>2</sub> Receptor
David F. Woodward, A M Bogardus, John E. Donello et al. · Journal of Ocular Pharmacology and Therapeutics · 1995 · 27 citations
Medicine, Molecular Biology, Pharmacology +11
1–5 of 8